Jpmorgan Chase & Co »

Emergent BioSolutions shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2012-06-30 $1.0M 67k 14.99
2010-12-31 $1.8M 78k 23.08

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf (SPY)
Meta Platforms Common (META)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Vanguard Total Intl Bond Etf Fund (BNDX)
Vanguard S&p 500 Etf idx (VOO)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Emergent BioSolutions

BlackRock
Vanguard Group
Charles Schwab Investment Management
Morgan Stanley
Millennium Management
Invesco
American Century Companies
Connor, Clark & Lunn Investment Management
D. E. Shaw & Co
Assenagon Asset Management
Hanna Zanoni
Jpmorgan Chase & Co
Goldman Sachs Group
Two Sigma Advisers
Geode Capital Management

View all funds holding Emergent BioSolutions